ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurologic Disorder Treatment Drug Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-9R11772
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Neurologic Disorder Treatment Drug Market Research Report 2022
BUY CHAPTERS

Global Neurologic Disorder Treatment Drug Market Research Report 2024

Code: QYRE-Auto-9R11772
Report
April 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
ACADIA Pharmaceuticals
Bayer
Biogen
CSK
Eisai Co Ltd
F.Hoffmann-La Roche
H.Lundbeck
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer Inc
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
UCB
Acorda Therapeutics Biotechnology
USWM

Neurologic Disorder Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neurologic Disorder Treatment Drug Market

Neurologic Disorder Treatment Drug Market

The global Neurologic Disorder Treatment Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neurologic Disorder Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurologic Disorder Treatment Drug.

Report Scope

The Neurologic Disorder Treatment Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurologic Disorder Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurologic Disorder Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurologic Disorder Treatment Drug Market Report

Report Metric Details
Report Name Neurologic Disorder Treatment Drug Market
CAGR 5%
Segment by Type
  • Anticholinergic
  • Antiepileptic
  • Antipsychotic
  • Hypnotic and Sedative
  • Analgesics
  • Antihypertensive
  • Anticoagulants
  • Others
Segment by Application
  • Epilepsy
  • Alzheimer’s Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Cerebrovascular Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Acadia Pharmaceuticals, Acorda Therapeutics Biotechnology, Bayer, Biogen, CSK, Eisai, F. Hoffmann La Roche, H Lundbeck, Johnson and Johnson, Merck, Novartis, Otsuka Pharmaceutical, Pfizer, Sanofi, Takeda Pharmaceutical, Teva Pharmaceutical Industries, UCB, USWM
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurologic Disorder Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurologic Disorder Treatment Drug Market report?

Ans: The main players in the Neurologic Disorder Treatment Drug Market are AbbVie, Acadia Pharmaceuticals, Acorda Therapeutics Biotechnology, Bayer, Biogen, CSK, Eisai, F. Hoffmann La Roche, H Lundbeck, Johnson and Johnson, Merck, Novartis, Otsuka Pharmaceutical, Pfizer, Sanofi, Takeda Pharmaceutical, Teva Pharmaceutical Industries, UCB, USWM

What are the Application segmentation covered in the Neurologic Disorder Treatment Drug Market report?

Ans: The Applications covered in the Neurologic Disorder Treatment Drug Market report are Epilepsy, Alzheimer’s Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others

What are the Type segmentation covered in the Neurologic Disorder Treatment Drug Market report?

Ans: The Types covered in the Neurologic Disorder Treatment Drug Market report are Anticholinergic, Antiepileptic, Antipsychotic, Hypnotic and Sedative, Analgesics, Antihypertensive, Anticoagulants, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anticholinergic
1.2.3 Antiepileptic
1.2.4 Antipsychotic
1.2.5 Hypnotic and Sedative
1.2.6 Analgesics
1.2.7 Antihypertensive
1.2.8 Anticoagulants
1.2.9 Others
1.3 Market by Application
1.3.1 Global Neurologic Disorder Treatment Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Epilepsy
1.3.3 Alzheimer’s Disease
1.3.4 Parkinson's Disease
1.3.5 Multiple Sclerosis
1.3.6 Cerebrovascular Disease
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurologic Disorder Treatment Drug Market Perspective (2019-2030)
2.2 Neurologic Disorder Treatment Drug Growth Trends by Region
2.2.1 Global Neurologic Disorder Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurologic Disorder Treatment Drug Historic Market Size by Region (2019-2024)
2.2.3 Neurologic Disorder Treatment Drug Forecasted Market Size by Region (2025-2030)
2.3 Neurologic Disorder Treatment Drug Market Dynamics
2.3.1 Neurologic Disorder Treatment Drug Industry Trends
2.3.2 Neurologic Disorder Treatment Drug Market Drivers
2.3.3 Neurologic Disorder Treatment Drug Market Challenges
2.3.4 Neurologic Disorder Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurologic Disorder Treatment Drug Players by Revenue
3.1.1 Global Top Neurologic Disorder Treatment Drug Players by Revenue (2019-2024)
3.1.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Players (2019-2024)
3.2 Global Neurologic Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurologic Disorder Treatment Drug Revenue
3.4 Global Neurologic Disorder Treatment Drug Market Concentration Ratio
3.4.1 Global Neurologic Disorder Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorder Treatment Drug Revenue in 2023
3.5 Neurologic Disorder Treatment Drug Key Players Head office and Area Served
3.6 Key Players Neurologic Disorder Treatment Drug Product Solution and Service
3.7 Date of Enter into Neurologic Disorder Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurologic Disorder Treatment Drug Breakdown Data by Type
4.1 Global Neurologic Disorder Treatment Drug Historic Market Size by Type (2019-2024)
4.2 Global Neurologic Disorder Treatment Drug Forecasted Market Size by Type (2025-2030)
5 Neurologic Disorder Treatment Drug Breakdown Data by Application
5.1 Global Neurologic Disorder Treatment Drug Historic Market Size by Application (2019-2024)
5.2 Global Neurologic Disorder Treatment Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurologic Disorder Treatment Drug Market Size (2019-2030)
6.2 North America Neurologic Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurologic Disorder Treatment Drug Market Size by Country (2019-2024)
6.4 North America Neurologic Disorder Treatment Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurologic Disorder Treatment Drug Market Size (2019-2030)
7.2 Europe Neurologic Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurologic Disorder Treatment Drug Market Size by Country (2019-2024)
7.4 Europe Neurologic Disorder Treatment Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurologic Disorder Treatment Drug Market Size (2019-2030)
8.2 Asia-Pacific Neurologic Disorder Treatment Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurologic Disorder Treatment Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurologic Disorder Treatment Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurologic Disorder Treatment Drug Market Size (2019-2030)
9.2 Latin America Neurologic Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurologic Disorder Treatment Drug Market Size by Country (2019-2024)
9.4 Latin America Neurologic Disorder Treatment Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurologic Disorder Treatment Drug Market Size (2019-2030)
10.2 Middle East & Africa Neurologic Disorder Treatment Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Neurologic Disorder Treatment Drug Introduction
11.1.4 AbbVie Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Acadia Pharmaceuticals
11.2.1 Acadia Pharmaceuticals Company Detail
11.2.2 Acadia Pharmaceuticals Business Overview
11.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Introduction
11.2.4 Acadia Pharmaceuticals Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.2.5 Acadia Pharmaceuticals Recent Development
11.3 Acorda Therapeutics Biotechnology
11.3.1 Acorda Therapeutics Biotechnology Company Detail
11.3.2 Acorda Therapeutics Biotechnology Business Overview
11.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Introduction
11.3.4 Acorda Therapeutics Biotechnology Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.3.5 Acorda Therapeutics Biotechnology Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Neurologic Disorder Treatment Drug Introduction
11.4.4 Bayer Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Neurologic Disorder Treatment Drug Introduction
11.5.4 Biogen Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.5.5 Biogen Recent Development
11.6 CSK
11.6.1 CSK Company Detail
11.6.2 CSK Business Overview
11.6.3 CSK Neurologic Disorder Treatment Drug Introduction
11.6.4 CSK Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.6.5 CSK Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai Neurologic Disorder Treatment Drug Introduction
11.7.4 Eisai Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.7.5 Eisai Recent Development
11.8 F. Hoffmann La Roche
11.8.1 F. Hoffmann La Roche Company Detail
11.8.2 F. Hoffmann La Roche Business Overview
11.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Introduction
11.8.4 F. Hoffmann La Roche Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.8.5 F. Hoffmann La Roche Recent Development
11.9 H Lundbeck
11.9.1 H Lundbeck Company Detail
11.9.2 H Lundbeck Business Overview
11.9.3 H Lundbeck Neurologic Disorder Treatment Drug Introduction
11.9.4 H Lundbeck Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.9.5 H Lundbeck Recent Development
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Detail
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Introduction
11.10.4 Johnson and Johnson Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.10.5 Johnson and Johnson Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Neurologic Disorder Treatment Drug Introduction
11.11.4 Merck Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Novartis
11.12.1 Novartis Company Detail
11.12.2 Novartis Business Overview
11.12.3 Novartis Neurologic Disorder Treatment Drug Introduction
11.12.4 Novartis Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.12.5 Novartis Recent Development
11.13 Otsuka Pharmaceutical
11.13.1 Otsuka Pharmaceutical Company Detail
11.13.2 Otsuka Pharmaceutical Business Overview
11.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Introduction
11.13.4 Otsuka Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.13.5 Otsuka Pharmaceutical Recent Development
11.14 Pfizer
11.14.1 Pfizer Company Detail
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Neurologic Disorder Treatment Drug Introduction
11.14.4 Pfizer Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.14.5 Pfizer Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Detail
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Neurologic Disorder Treatment Drug Introduction
11.15.4 Sanofi Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.15.5 Sanofi Recent Development
11.16 Takeda Pharmaceutical
11.16.1 Takeda Pharmaceutical Company Detail
11.16.2 Takeda Pharmaceutical Business Overview
11.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Introduction
11.16.4 Takeda Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.16.5 Takeda Pharmaceutical Recent Development
11.17 Teva Pharmaceutical Industries
11.17.1 Teva Pharmaceutical Industries Company Detail
11.17.2 Teva Pharmaceutical Industries Business Overview
11.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Introduction
11.17.4 Teva Pharmaceutical Industries Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.17.5 Teva Pharmaceutical Industries Recent Development
11.18 UCB
11.18.1 UCB Company Detail
11.18.2 UCB Business Overview
11.18.3 UCB Neurologic Disorder Treatment Drug Introduction
11.18.4 UCB Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.18.5 UCB Recent Development
11.19 USWM
11.19.1 USWM Company Detail
11.19.2 USWM Business Overview
11.19.3 USWM Neurologic Disorder Treatment Drug Introduction
11.19.4 USWM Revenue in Neurologic Disorder Treatment Drug Business (2019-2024)
11.19.5 USWM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AbbVie
ACADIA Pharmaceuticals
Bayer
Biogen
CSK
Eisai Co Ltd
F.Hoffmann-La Roche
H.Lundbeck
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer Inc
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
UCB
Acorda Therapeutics Biotechnology
USWM
List of Tables
    Table 1. Global Neurologic Disorder Treatment Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Anticholinergic
    Table 3. Key Players of Antiepileptic
    Table 4. Key Players of Antipsychotic
    Table 5. Key Players of Hypnotic and Sedative
    Table 6. Key Players of Analgesics
    Table 7. Key Players of Antihypertensive
    Table 8. Key Players of Anticoagulants
    Table 9. Key Players of Others
    Table 10. Global Neurologic Disorder Treatment Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Neurologic Disorder Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Neurologic Disorder Treatment Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Neurologic Disorder Treatment Drug Market Share by Region (2019-2024)
    Table 14. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Neurologic Disorder Treatment Drug Market Share by Region (2025-2030)
    Table 16. Neurologic Disorder Treatment Drug Market Trends
    Table 17. Neurologic Disorder Treatment Drug Market Drivers
    Table 18. Neurologic Disorder Treatment Drug Market Challenges
    Table 19. Neurologic Disorder Treatment Drug Market Restraints
    Table 20. Global Neurologic Disorder Treatment Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Neurologic Disorder Treatment Drug Market Share by Players (2019-2024)
    Table 22. Global Top Neurologic Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2023)
    Table 23. Ranking of Global Top Neurologic Disorder Treatment Drug Companies by Revenue (US$ Million) in 2023
    Table 24. Global 5 Largest Players Market Share by Neurologic Disorder Treatment Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Neurologic Disorder Treatment Drug Product Solution and Service
    Table 27. Date of Enter into Neurologic Disorder Treatment Drug Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Neurologic Disorder Treatment Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Neurologic Disorder Treatment Drug Revenue Market Share by Type (2019-2024)
    Table 31. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Neurologic Disorder Treatment Drug Revenue Market Share by Type (2025-2030)
    Table 33. Global Neurologic Disorder Treatment Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Neurologic Disorder Treatment Drug Revenue Market Share by Application (2019-2024)
    Table 35. Global Neurologic Disorder Treatment Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Neurologic Disorder Treatment Drug Revenue Market Share by Application (2025-2030)
    Table 37. North America Neurologic Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Neurologic Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Neurologic Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Neurologic Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Europe Neurologic Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Europe Neurologic Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Asia-Pacific Neurologic Disorder Treatment Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Asia-Pacific Neurologic Disorder Treatment Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 45. Asia-Pacific Neurologic Disorder Treatment Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 46. Latin America Neurologic Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Latin America Neurologic Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Latin America Neurologic Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 50. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 51. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 52. AbbVie Company Detail
    Table 53. AbbVie Business Overview
    Table 54. AbbVie Neurologic Disorder Treatment Drug Product
    Table 55. AbbVie Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 56. AbbVie Recent Development
    Table 57. Acadia Pharmaceuticals Company Detail
    Table 58. Acadia Pharmaceuticals Business Overview
    Table 59. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product
    Table 60. Acadia Pharmaceuticals Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 61. Acadia Pharmaceuticals Recent Development
    Table 62. Acorda Therapeutics Biotechnology Company Detail
    Table 63. Acorda Therapeutics Biotechnology Business Overview
    Table 64. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product
    Table 65. Acorda Therapeutics Biotechnology Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 66. Acorda Therapeutics Biotechnology Recent Development
    Table 67. Bayer Company Detail
    Table 68. Bayer Business Overview
    Table 69. Bayer Neurologic Disorder Treatment Drug Product
    Table 70. Bayer Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 71. Bayer Recent Development
    Table 72. Biogen Company Detail
    Table 73. Biogen Business Overview
    Table 74. Biogen Neurologic Disorder Treatment Drug Product
    Table 75. Biogen Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 76. Biogen Recent Development
    Table 77. CSK Company Detail
    Table 78. CSK Business Overview
    Table 79. CSK Neurologic Disorder Treatment Drug Product
    Table 80. CSK Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 81. CSK Recent Development
    Table 82. Eisai Company Detail
    Table 83. Eisai Business Overview
    Table 84. Eisai Neurologic Disorder Treatment Drug Product
    Table 85. Eisai Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 86. Eisai Recent Development
    Table 87. F. Hoffmann La Roche Company Detail
    Table 88. F. Hoffmann La Roche Business Overview
    Table 89. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product
    Table 90. F. Hoffmann La Roche Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 91. F. Hoffmann La Roche Recent Development
    Table 92. H Lundbeck Company Detail
    Table 93. H Lundbeck Business Overview
    Table 94. H Lundbeck Neurologic Disorder Treatment Drug Product
    Table 95. H Lundbeck Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 96. H Lundbeck Recent Development
    Table 97. Johnson and Johnson Company Detail
    Table 98. Johnson and Johnson Business Overview
    Table 99. Johnson and Johnson Neurologic Disorder Treatment Drug Product
    Table 100. Johnson and Johnson Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 101. Johnson and Johnson Recent Development
    Table 102. Merck Company Detail
    Table 103. Merck Business Overview
    Table 104. Merck Neurologic Disorder Treatment Drug Product
    Table 105. Merck Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 106. Merck Recent Development
    Table 107. Novartis Company Detail
    Table 108. Novartis Business Overview
    Table 109. Novartis Neurologic Disorder Treatment Drug Product
    Table 110. Novartis Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 111. Novartis Recent Development
    Table 112. Otsuka Pharmaceutical Company Detail
    Table 113. Otsuka Pharmaceutical Business Overview
    Table 114. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product
    Table 115. Otsuka Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 116. Otsuka Pharmaceutical Recent Development
    Table 117. Pfizer Company Detail
    Table 118. Pfizer Business Overview
    Table 119. Pfizer Neurologic Disorder Treatment Drug Product
    Table 120. Pfizer Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 121. Pfizer Recent Development
    Table 122. Sanofi Company Detail
    Table 123. Sanofi Business Overview
    Table 124. Sanofi Neurologic Disorder Treatment Drug Product
    Table 125. Sanofi Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 126. Sanofi Recent Development
    Table 127. Takeda Pharmaceutical Company Detail
    Table 128. Takeda Pharmaceutical Business Overview
    Table 129. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product
    Table 130. Takeda Pharmaceutical Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 131. Takeda Pharmaceutical Recent Development
    Table 132. Teva Pharmaceutical Industries Company Detail
    Table 133. Teva Pharmaceutical Industries Business Overview
    Table 134. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product
    Table 135. Teva Pharmaceutical Industries Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 136. Teva Pharmaceutical Industries Recent Development
    Table 137. UCB Company Detail
    Table 138. UCB Business Overview
    Table 139. UCB Neurologic Disorder Treatment Drug Product
    Table 140. UCB Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 141. UCB Recent Development
    Table 142. USWM Company Detail
    Table 143. USWM Business Overview
    Table 144. USWM Neurologic Disorder Treatment Drug Product
    Table 145. USWM Revenue in Neurologic Disorder Treatment Drug Business (2019-2024) & (US$ Million)
    Table 146. USWM Recent Development
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurologic Disorder Treatment Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Neurologic Disorder Treatment Drug Market Share by Type: 2023 VS 2030
    Figure 3. Anticholinergic Features
    Figure 4. Antiepileptic Features
    Figure 5. Antipsychotic Features
    Figure 6. Hypnotic and Sedative Features
    Figure 7. Analgesics Features
    Figure 8. Antihypertensive Features
    Figure 9. Anticoagulants Features
    Figure 10. Others Features
    Figure 11. Global Neurologic Disorder Treatment Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 12. Global Neurologic Disorder Treatment Drug Market Share by Application: 2023 VS 2030
    Figure 13. Epilepsy Case Studies
    Figure 14. Alzheimer’s Disease Case Studies
    Figure 15. Parkinson's Disease Case Studies
    Figure 16. Multiple Sclerosis Case Studies
    Figure 17. Cerebrovascular Disease Case Studies
    Figure 18. Others Case Studies
    Figure 19. Neurologic Disorder Treatment Drug Report Years Considered
    Figure 20. Global Neurologic Disorder Treatment Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 21. Global Neurologic Disorder Treatment Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Neurologic Disorder Treatment Drug Market Share by Region: 2023 VS 2030
    Figure 23. Global Neurologic Disorder Treatment Drug Market Share by Players in 2023
    Figure 24. Global Top Neurologic Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorder Treatment Drug as of 2023)
    Figure 25. The Top 10 and 5 Players Market Share by Neurologic Disorder Treatment Drug Revenue in 2023
    Figure 26. North America Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. North America Neurologic Disorder Treatment Drug Market Share by Country (2019-2030)
    Figure 28. United States Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Canada Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Europe Neurologic Disorder Treatment Drug Market Share by Country (2019-2030)
    Figure 32. Germany Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Asia-Pacific Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Asia-Pacific Neurologic Disorder Treatment Drug Market Share by Region (2019-2030)
    Figure 40. China Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Japan Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Latin America Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Latin America Neurologic Disorder Treatment Drug Market Share by Country (2019-2030)
    Figure 48. Mexico Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Brazil Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Neurologic Disorder Treatment Drug Market Share by Country (2019-2030)
    Figure 52. Turkey Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Neurologic Disorder Treatment Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. AbbVie Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 55. Acadia Pharmaceuticals Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 56. Acorda Therapeutics Biotechnology Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 57. Bayer Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 58. Biogen Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 59. CSK Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 60. Eisai Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 61. F. Hoffmann La Roche Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 62. H Lundbeck Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 63. Johnson and Johnson Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 66. Otsuka Pharmaceutical Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 68. Sanofi Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 69. Takeda Pharmaceutical Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 70. Teva Pharmaceutical Industries Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 71. UCB Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 72. USWM Revenue Growth Rate in Neurologic Disorder Treatment Drug Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs of Neuron Management Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurodegenerative Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurology Digital Therapeutics Market
Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intracranial Treatment Drug Market Research Report 2025
AI Assisted Diagnosis in Neurology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Specific Learning Disability Treatment Market Research Report 2025
Global Spine Disorders Treatment Market Research Report 2024
Central Nervous System Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Optic Neuritis Drug Market Research Report 2025
Global Alzheimer s Treatment Drug Market Research Report 2024
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Parkinson Treatment Drug Market Research Report 2025
Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Clinical Treatment Drug Market Research Report 2025
Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorder Treatment Market Research Report 2024

RELATED REPORTS

Global Autism Spectrum Disorder Educational Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B19448
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Spinal Cord Stimulation Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-11Z11048
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Attention-Deficit Hyperactivity Disorder (ADHD) Medications Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26G17123
Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Hydrocephalus Shunts Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-9139
Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions